Back to search

Article

The potent <i>Toxoplasma gondii</i> growth inhibitor QQ-437 does not bind to its predicted target, parasite adaptin3 <i>β</i> , in yeast three-hybrid assays

2022-06-08

Abstract excerpt

New drugs are needed to treat infections with Toxoplasma gondii , a ubiquitous protozoan parasite that can cause miscarriage, blindness, and life-threatening encephalitis in its human hosts. A novel N-benzoyl-2-hydroxybenzamide named QQ-437 was recently shown to be a potent inhibitor of T. gondii growth in vitro (EC 50 = 16nM), and to reduce parasite load in a mouse model of infection. Intriguingly, mutations...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
91391322-095b-50f2-af42-d051fc470688
DOI
10.1101/2022.06.07.495217
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The potent <i>Toxoplasma gondii</i> growth inhibitor QQ-437 does not bind to its predicted target, parasite adaptin3 <i>β</i> , in yeast three-hybrid assaysDOI 10.1101/2022.06.07.495217
Select a neighboring publication to make it the new centre.